Iovance Biotherapeutics (IOVA) Stock: Buy, Sell, or Hold?
IOVA - Iovance Biotherapeutics, Inc. Common Stock
$14.22
-0.02 (-0.11%)
▼
5d:
+29.23%
30d:
+64.91%
90d:
+239.26%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Sep 30, 2026 at $15.06 · last confirmed Oct 2, 2026
Strength: 9.0/10
Get Alerted When IOVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: IOVA is 19.0% above its trading range ($11.95). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: IOVA is 19.0% above its trading range ($11.95). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: IOVA is currently trading at $14.21, which is considered extended relative to its 30-day fair value range of $7.88 to $11.95.
Technical Outlook: Technically, IOVA is in a strong uptrend. Immediate support is located at $10.03, while resistance sits at $15.30.
Market Sentiment: IOVA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IOVA is in a strong uptrend. Immediate support is located at $10.03, while resistance sits at $15.30.
Market Sentiment: IOVA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.88 -
$11.95
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
7.9%
All Signals
- BEARISH: Price significantly overextended (+19.0% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($12.80)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.88 -
$11.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$10.03
Resistance Level
$15.30
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-59.98
Wall Street Target
$12.80
(-10.0%)
Revenue Growth (YoY)
65.7%
Profit Margin
-89.1%
Share & Embed Analysis
Last updated: October 02, 2026 9:22 PM ET
Data refreshes hourly during market hours. Next update: 10:22 PM
Data refreshes hourly during market hours. Next update: 10:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IOVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 63 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$21 | 50 HOLD |
